Related Experiment Videos
Serum interleukin-2 levels associate with disease activity and cardiovascular risk in patients with rheumatoid
Miguel Ángel González-Gay1, Juan Carlos Quevedo-Abeledo2, Cristina Almeida-Santiago2
1Division of Rheumatology, IIS-Fundación Jiménez Díaz, Madrid; and Department of Medicine and Psychiatry, University of Cantabria, Santander, Spain. miguelaggay@hotmail.com.
Objectives:
Interleukin-2 (IL-2) plays anti-inflammatory and immunoregulatory roles and has been implicated in the pathogenesis of rheumatoid arthritis (RA). However, the relationship between its circulating serum levels and specific clinical features of the disease remains unclear. In this study, we aimed to investigate the association between serum IL-2 concentrations and a wide range of RA-related characteristics, including cardiovascular comorbidities.
Methods:
216 RA patients underwent assessments of disease characteristics and activity indices. Lipid profile was obtained, insulin resistance indices were calculated, and metabolic syndrome criteria were applied. Carotid ultrasound examinations were performed to assess arterial stiffness, intima-media thickness, and the presence of carotid plaques. Cardiovascular risk was estimated using the SCORE2 tool. Serum IL-2 levels were measured using the Simoa (Single Molecule Array) technique. Finally, a multivariable linear regression analysis was conducted to explore the associations between disease characteristics and IL-2 levels.
Results:
After multivariable adjustment, IL-2 was independently and positively associated with disease activity. Patients positive for rheumatoid factor and anti-citrullinated protein antibodies also exhibited significantly higher IL-2 levels than seronegative individuals. Furthermore, IL-2 showed a positive relationship with pancreatic beta-cell function. Notably, circulating IL-2 concentrations were significantly associated with increased cardiovascular risk as estimated by the SCORE2 algorithm.
Conclusions:
Circulating IL-2 levels are independently and positively associated with both disease activity and cardiovascular risk in patients with RA. These findings further emphasise the pivotal role of IL-2 in the pathophysiology of RA and its associated cardiovascular comorbidities, highlighting IL-2 as a potential biomarker and therapeutic target in this population.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
The JAK-STAT Signaling Pathway
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease I: Introduction